Home » Stocks » IMLFF

InMed Pharmaceuticals, Inc. (IMLFF)

Nov 16, 2020 - Stock symbol was changed to INM
Stock Price: $3.29 USD -0.11 (-3.24%)
Updated Nov 17, 2021 9:30 AM EST
Market Cap 23.25M
Revenue (ttm) n/a
Net Income (ttm) -12.36M
Shares Out 5.22M
EPS (ttm) -0.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day Nov 17, 2021
Last Price $3.29
Previous Close $3.40
Change ($) -0.11
Change (%) -3.24%
Day's Open 3.44
Day's Range 3.26 - 3.44
Day's Volume 71,935
52-Week Range 3.04 - 10.428

News

There are no news available yet.

About IMLFF

InMed Pharmaceuticals, a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of orofacial pain. In addition, it engages in the development of cannabinoid-based treatments for various diseases, including dermat... [Read more...]

Industry
Biotechnology
CEO
Eric A. Adams
Country
Canada
Stock Exchange
OTCMKTS
Ticker Symbol
IMLFF
Full Company Profile